498 related articles for article (PubMed ID: 17431185)
1. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
[TBL] [Abstract][Full Text] [Related]
2. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states.
Perez-Martinez P; Corella D; Shen J; Arnett DK; Yiannakouris N; Tai ES; Orho-Melander M; Tucker KL; Tsai M; Straka RJ; Province M; Kai CS; Perez-Jimenez F; Lai CQ; Lopez-Miranda J; Guillen M; Parnell LD; Borecki I; Kathiresan S; Ordovas JM
Am J Clin Nutr; 2009 Jan; 89(1):391-9. PubMed ID: 19056598
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-V genetic variation and plasma lipoprotein response to fibrates.
Hegele RA; Pollex RL
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1224-7. PubMed ID: 17522394
[No Abstract] [Full Text] [Related]
4. The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study.
Cardona F; Guardiola M; Queipo-Ortuño MI; Murri M; Ribalta J; Tinahones FJ
Atherosclerosis; 2009 Sep; 206(1):148-52. PubMed ID: 19344899
[TBL] [Abstract][Full Text] [Related]
5. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study.
Irvin MR; Kabagambe EK; Tiwari HK; Parnell LD; Straka RJ; Tsai M; Ordovas JM; Arnett DK
Circ Cardiovasc Genet; 2010 Oct; 3(5):462-7. PubMed ID: 20729559
[TBL] [Abstract][Full Text] [Related]
7. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
8. Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the -1131T>C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design).
Kim JY; Kim OY; Koh SJ; Jang Y; Yun SS; Ordovas JM; Lee JH
J Am Coll Nutr; 2006 Aug; 25(4):340-7. PubMed ID: 16943456
[TBL] [Abstract][Full Text] [Related]
9. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
[TBL] [Abstract][Full Text] [Related]
10. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
11. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK
Pharmacogenet Genomics; 2009 Feb; 19(2):161-9. PubMed ID: 19057464
[TBL] [Abstract][Full Text] [Related]
13. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population.
Moreno-Luna R; Perez-Jimenez F; Marin C; Perez-Martinez P; Gomez P; Jimenez-Gomez Y; Delgado-Lista J; Moreno JA; Tanaka T; Ordovas JM; Lopez-Miranda J
J Clin Endocrinol Metab; 2007 Jun; 92(6):2280-5. PubMed ID: 17356049
[TBL] [Abstract][Full Text] [Related]
14. Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.
Brautbar A; Covarrubias D; Belmont J; Lara-Garduno F; Virani SS; Jones PH; Leal SM; Ballantyne CM
Atherosclerosis; 2011 Dec; 219(2):737-42. PubMed ID: 21889769
[TBL] [Abstract][Full Text] [Related]
15. Changes of plasma lipids during weight reduction in females depends on APOA5 variants.
Suchanek P; Lorenzova A; Poledne R; Hubacek JA
Ann Nutr Metab; 2008; 53(2):104-8. PubMed ID: 18946207
[TBL] [Abstract][Full Text] [Related]
16. Differential Lipid Response to Statins Is Associated With Variants in the BUD13-APOA5 Gene Region.
OʼBrien SE; Schrodi SJ; Ye Z; Brilliant MH; Virani SS; Brautbar A
J Cardiovasc Pharmacol; 2015 Aug; 66(2):183-8. PubMed ID: 25900265
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults.
Badiou S; Merle De Boever C; Dupuy AM; Baillat V; Cristol JP; Reynes J
Atherosclerosis; 2004 Feb; 172(2):273-9. PubMed ID: 15019537
[TBL] [Abstract][Full Text] [Related]
18. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
19. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
[TBL] [Abstract][Full Text] [Related]
20. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
